It Seems Xenetic Biosciences Inc (NASDAQ:XBIO) Will Go Down. Just Reported More Shorted Shares

Xenetic Biosciences, Inc. (NASDAQ:XBIO) Logo

The stock of Xenetic Biosciences Inc (NASDAQ:XBIO) registered an increase of 43.97% in short interest. XBIO’s total short interest was 33,400 shares in July as published by FINRA. Its up 43.97% from 23,200 shares, reported previously. With 24,800 shares average volume, it will take short sellers 1 days to cover their XBIO’s short positions. The short interest to Xenetic Biosciences Inc’s float is 0.99%.

The stock increased 15.30% or $1.68 during the last trading session, reaching $12.69. About 68,185 shares traded or 23.59% up from the average. Xenetic Biosciences, Inc. (NASDAQ:XBIO) has declined 34.60% since July 14, 2018 and is downtrending. It has underperformed by 39.03% the S&P500.

Xenetic Biosciences, Inc., a clinical stage biopharmaceutical company, focuses on the discovery, research, and development of biologic drugs and orphan oncology therapeutics. The company has market cap of $11.05 million. The Company’s lead proprietary technology is PolyXen, a platform technology for biologic drug delivery. It currently has negative earnings. The companyÂ’s lead drug candidate is XBIO-101, a small-molecule immunomodulator and interferon inducer for the treatment of progesterone receptor negative endometrial cancer and triple negative breast cancer.

More notable recent Xenetic Biosciences, Inc. (NASDAQ:XBIO) news were published by: Seekingalpha.com which released: “Xenetic Bio readies equity offering; shares down 8% premarket – Seeking Alpha” on July 02, 2019, also Seekingalpha.com with their article: “Microcaps mostly among midday movers – Seeking Alpha” published on July 08, 2019, Streetinsider.com published: “Form S-1/A Xenetic Biosciences, – StreetInsider.com” on June 24, 2019. More interesting news about Xenetic Biosciences, Inc. (NASDAQ:XBIO) were released by: Nasdaq.com and their article: “U.S. STOCKS ON THE MOVE-Apple, GE, Boeing, Coherus, NetApp – Nasdaq” published on July 08, 2019 as well as Streetinsider.com‘s news article titled: “Xenetic Biosciences (XBIO) Prices $3.1M Registered Direct Offering – StreetInsider.com” with publication date: March 05, 2019.

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.